Clinical Trial Update: Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic Syndromes [Phase 1]

View source ↗

Summary

A Phase 1 trial update exploring dose escalation of cladribine in conditioning regimens before allogeneic stem cell transplantation for refractory acute leukemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Cladribine (cladribine)

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute | Phase 1 | Status: UNKNOWN